Aldrin and dieldrin: a reevaluation of the cancer and noncancer dose-response assessments.

The dose-response analyses of cancer and noncancer health effects of aldrin and dieldrin were evaluated using current methodology, including benchmark dose analysis and the current U.S. Environmental Protection Agency (U.